Event-Driven Stocks

SpringWorks Therapeutics, Inc.

SWTX

Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 3 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY24FY23FY22FY21FY20FY19
Revenue$172.0M$5.4M$0$0$35.0M$0
Operating income−$278.1M−$343.0M−$280.7M−$173.5M−$46.3M−$59.2M
Net income−$258.1M−$325.1M−$277.4M−$173.9M−$45.6M−$58.3M
Total assets$587.3M$725.8M$630.2M$452.5M$576.2M$334.8M
Total liabilities$106.2M$99.6M$72.0M$30.1M$19.1M$12.8M
Equity$481.1M$626.2M$558.2M$422.4M$557.1M$322.1M
EPS (diluted)$-3.48$-5.15$-5.21$-3.59$-1.05—
Shares out.73.8M62.5M49.3M49.0M43.0M43.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2024
Operating margin
−161.7%
Net margin
−150.0%
Return on equity
−53.7%
Return on assets
−44.0%
Return on capital (ROCE)
−57.1%
Liabilities / assets
18.1%
Debt / equity
0.22×
Book value / share
$6.52
Revenue growth (YoY)
3058.5%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2024
Altman Z″ (distress)
-1.69distress
Accruals / assets
−14.1%clean
Beneish M-Score
23.51elevated
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 67Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 3 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

FDA-approved drugs

openFDA · most recent
  • GOMEKLIFeb 11, 2025
  • OGSIVEONov 27, 2023

Clinical trials

ClinicalTrials.gov · ongoing · next readout first

Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
Jun 30, 20256.9M1.3+8.5%
Jun 13, 20256.4M1.5+2.2%
May 30, 20256.2M1.4+4.8%
May 15, 20256.0M1.1+13.1%
Apr 30, 20255.3M1.0-33.5%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.